Prerecorded Webinar: Kidney Connection: Insights into Chronic Kidney Disease Management for the Interdisciplinary Healthcare Team
Pre-Recorded
Are you a Pharmacist? Check out the Pharmacist version of this course.
Want another way to take this test? Check out the written version of this course.
Course Summary
Chronic Kidney Disease (CKD) remains a significant public health problem with the evolving landscape of diagnosis, management, and patient care. As new research insights emerge and treatment paradigms shift, it is imperative for healthcare professionals to stay current with the latest recommendations and care models. This monograph will provide an overview of the management of CKD, highlighting updates from the 2022 KDIGO guidelines and focusing on updates in pharmacotherapeutics and components of comprehensive care plans.
Course Objectives
Identify the latest diagnostic tools, biomarkers, and imaging techniques for early and accurate detection of CKD and differentiation between the stages of CKD
Recall therapeutic management strategies for patients with CKD
Describe components of comprehensive care plans for patients with CKD and diabetes and patients with CKD and heart disease
I. Introduction
II. Definitions and Classification
III. Epidemiology and Etiology
IV. Comprehensive Care for Patients with CKD
1. Diabetes
2. Hypertension
V. Pharmacotherapeutic Strategies
1. SGLT2-i
2. GLP-1 receptor agonists
3. Non-steriodal mineralocorticoid antagonists
4. ACE-I and ARBs
5. Calcium channel blockers
VI. Renal dosing
1. Contraindicated medications
2. Changing criteria for renal dosing
VII. Summary
- Read the course objectives and faculty planner disclosure
- Read the course material
- Complete the post-test with a minimum score of 70% and complete the course evaluation form.
- Results are automatically submitted to CPE Monitor
Faculty Planner Disclosure
The following individuals were involved in the development of this activity: Liz Fredrickson, PharmD, BCPS, and Pamela Sardo, PharmD, BS. Pamela Sardo was an employee of Rhythm Pharmaceuticals until March 2022 and has no conflicts of interest or relationships regarding the subject matter discussed. There are no financial relationships relevant to this activity to report or disclose by any of the individuals involved in the development of this activity.
Unlabeled Use Disclosures
The information provided in this course is general in nature and it is solely designed to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant’s professional practice, including but not limited to patient assessment, diagnosis, treatment and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals, including pharmacists and pharmacy technicians, must consult with their employer, healthcare facility, hospital, or other organization, for guidelines, protocols, and procedures they are to follow. The information provided in this course does not replace those guidelines, protocols, and procedures but is for academic purposes only, and this course’s limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses are constantly changing, and any person taking this course understands that such person must make an independent review of medication information prior to any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of RxCe.com LLC. RxCe.com LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course, or course material.
Computer Hardware/Software Requirements
Please ensure the device you plan to use meets these requirements and specifications:
- Operating System: Windows 7,8,10, or 11 /Mac OS X 10.9 or later/iOS/Android
- Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
- A connection to the internet
- For Live Webinars or Conferences: GoToWebinar application for iOS, Android, Mac, or PC. You cannot 'call into' a live conference.
Rating: 4.9/5
Based on the ratings of 20 customers
- Target Audience: Pharmacy Tech
- Contact Hours: 1.0 (0.1 CEUs)
- Activity Release Date: 12/2/2023
- Activity Expiration Date: 12/2/2026
- Activity Type: Knowledge
- UAN: 0669-0000-23-198-H01-T
- Topic: Disease State Management/Drug Therapy
- CeBroker Number: 20-1134186
Author:
Preview the Materials:
RxCe.com, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
RxCe.com, LLC, offers pharmacy technician continuing education courses for PTCB recertification. Pharmacy technician courses are indicated both in the Target Audience description and the ACPE UAN which will end with a "T".